Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing long-term outcomes of donor livers preserved with machine perfusion

Official title: Prospective Observational Study to Investigate Long-term Outcomes After Prolonged Dual Hypothermic Oxygenated Machine Perfusion of Human Donor Livers (DHOPEPROLONG)

Run by University Medical Center Groningen · NCT05680246 · Data updated 2026-11-12

This study looks at whether using a special machine to keep donor livers healthy for longer before transplant can help people have better long-term outcomes after their liver surgery.

More Liver Transplantation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorUniversity Medical Center Groningen
Academic / other
Locations1 site (Groningen)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 2028
Study endsDecember 2033
Registry record updatedMay 21, 2024
Trial IDNCT05680246 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult patients over 18 years old who have undergone liver transplantation using donor livers preserved with DHOPE for more than four hours.

Probably not a fit

Patients who received liver transplants from donors preserved using methods other than DHOPE may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term outcomes of liver transplants using donor livers preserved through prolonged dual hypothermic oxygenated machine perfusion (DHOPE). The study focuses on real-world data to assess the effectiveness of DHOPE in reducing complications associated with liver transplantation, such as ischemia-reperfusion injury and early allograft dysfunction. By analyzing outcomes from adult patients who received liver transplants after DHOPE preservation for more than four hours, the study seeks to fill the gap in existing evidence regarding the long-term benefits of this preservation method.

Why it matters

Potential benefit: If successful, this study could lead to improved long-term outcomes for liver transplant recipients by minimizing complications associated with organ preservation.

How similar studies have gone: While the approach of using DHOPE for liver preservation is advancing, this specific long-term outcome assessment is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (\>18 years) who underwent liver transplantation of donor livers preserved with end-ischemic DHOPE for \>4 hours

Exclusion Criteria:

* None

Where it's running

  • University Medical Center Groningen
    Groningen, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Vincent E de Meijer, MD, PhD — University Medical Center Groningen
  • Study coordinator: Vincent E de Meijer, MD, PhD
  • Email: v.e.de.meijer@umcg.nl
  • Phone: +31503616161

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.